Francisco Javier Ortiz-López

13PUBLICATIONS
24CO-AUTHORS
GlycoconjugatesCheminformatics and quantitative structure-activity relationshipsGenomicsBiologically active moleculesIndustrial molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 03, 2025
Dracomicins, Hybrid Oligosaccharide-Nonribosomal Peptide Antibiotics from Amycolatopsis Species.

Francisco Javier Ortiz-López, Daniel Oves-Costales, José Murillo-Alba

|Sep 27, 2024
Genome-Led Discovery of the Antibacterial Cyclic Lipopeptide Kutzneridine A and Its Silent Biosynthetic Gene Cluster from Kutzneria Species.

Francisco Javier Ortiz-López, Daniel Oves-Costales, Jaime Felipe Guerrero Garzón

|Feb 08, 2024
Dilarmycins A-C, Calcium-Dependent Lipopeptide Antibiotics with a Non-canonical Ca2+-Binding Motif.

Ignacio Fernández-Pastor, Francisco Javier Ortiz-López, Daniel Oves-Costales

|May 10, 2023
Crossiellidines A-F, Unprecedented Pyrazine-Alkylguanidine Metabolites with Broad-Spectrum Antibacterial Activity from Crossiella sp.

Francisco Javier Ortiz-López, Daniel Oves-Costales, Daniel Carretero-Molina

|Nov 13, 2021
Activation and Identification of a Griseusin Cluster in Streptomyces sp. CA-256286 by Employing Transcriptional Regulators and Multi-Omics Methods.

Charlotte Beck, Tetiana Gren, Francisco Javier Ortiz-López

Pageof 3